A Randomized, Open-label Study of the Safety and Efficacy of Multi- Vessel Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With Cardiomyopathy Secondary to Duchenne Muscular Dystrophy

Clinical Trial OPEN
Jefferies, John L;
  • Publisher: nct

Approximately 24, and not more than 30, subjects will be randomized into the study, in two sequential enrollment groups. Safety data from Group 1 will undergo a Data Safety Monitoring Board (DSMB) review prior to initiation of enrollment for Group 2. The first 6-8 rando... View more
Share - Bookmark

  • Download from
    OpenTrials via OpenTrials (Clinical Trial)
  • Cite this research data